logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Galena Biopharma (GALE) Plunges as Concerns over Scandal Continue

By  +Follow February 14, 2014 5:26AM
Share:
Tickers Mentioned:

Share in Galena Biopharma (GALE) plunged nearly 25 percent to begin trading Friday on heavy volume as the fallout from the company’s stock promotion scandal appears to continue. The sell-off appeared to break through a major technical barrier that had developed in recent months, causing the drop to pick up steam as the morning wore on.

GALE Hammered Again on Heavy Volume

Shares of Galena were moving fast on Friday morning as the stock went into freefall soon after the opening bell. Without any specific news appearing to drive the drop, the sell-off appears to be motivated by speculators, residual negative sentiment from Wednesday’s revelations that the company was paying a marketing firm to pump its stock, or some combination of both.

The fall paused briefly at 10 am after the stock reached $4 a share, a price that had been acting as a support level since mid-December. However, after circling the drain for about 15 minutes, the selling resumed and Galena appeared to break through said support level firmly. Shares then kept falling, reaching $3.30 a share before starting to bounce back just after 11 am.

Pipeline Must Produce

The good news for Galena investors is that the company currently has what appears to be a robust product pipeline in place. Oral pain treatment Abstral has already been approved for use in the market and was officially launched in October. However, some Galena shorts estimate that the drug’s 5 percent market share will ultimately only net $20 million to $30 million for Galena.

Meanwhile, the company also has three different drugs currently in various stages of development: NeuVax, GALE-401, and GALE-301, a Folate Binding Protein vaccine for ovarian and endometrial cancer patients. NeuVax is currently in two separate trials to test its efficacy in treating breast cancer (one is testing the drug in combination with Herceptin), with a third trial in planning to test its effect on gastric cancer patients.

Galena’s website describes NeuVax as follows: “NeuVax consists of the E75 peptide derived from HER2 combined with the immune adjuvant granulocyte macrophage colony stimulating factor (GM-CSF).  Treatment with NeuVax stimulates cytotoxic (CD8+) T cells in a highly specific manner to target cells expressing any level of HER2.  NeuVax is given as an intradermal injection once a month for six months, followed by a booster injection once every six months.”

Herceptin, which is only available as a treatment to a quarter of women affected by breast cancer, had revenues of $5 billion in 2010, giving Galena hope that sunnier days are around the corner. However, the recent revelations of stock promotion may place extra pressure on future clinical results for the company.

Noble Financial’s Endorsement Not a Timely One

The plummeting share price for Galena comes just two weeks after Noble Financial reiterated its buy rating on the stock and raised the price target from $4 to $6 a share.

“With improved pk metrics GALE-401 may be more effective without the tolerability/safety issues of Anagrelide-IR; could capture larger market share over HU; US sales potential of $150 to $200M; 8K new cases of ET each year and 80-100K prevalence in US ... Company has discussed with FDA, GALE-401 will be developed under 505b2 path for ET with Anagrelide-IR as reference drug; Phase 2 studies to begin shortly; could be on the market late 2017 or early 2018,” Analyst Rahul Jasuja noted.

Analysts have been kind to Galena in 2014, with two other analysts weighing in on Tuesday, Jan. 21. Maxim Group rated the stock a buy and raised its price target from $9 to $11, while Needham & Company increased their own price target to $9 a share. That makes five different research analysts rating the stock a buy, and the average price target for the company is $7.64 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for GALE
Michael James
29 Aug 15 11:05:57
Subscribers Saw A 525% Gain On $GEQU & A SECRET New Pick Is Out! See The Private Info: http://t.co/RzgF9M02nG $ETEK $GALE $RSOL
Michael Cook
29 Aug 15 11:05:28
After 3,000% Gains In The Past Year, We Have A Major New Pick Out! Big Update: http://t.co/QTGaTmijJY $ETEK $GALE $RSOL
Paul Henry
29 Aug 15 10:58:54
We Sent A SECRET New Penny Stock Pick To Our Platinum Members! Get Exclusive Special Access: http://t.co/sJCFystTVz $ETEK $GALE $RSOL
$Stocknewsalerts
29 Aug 15 09:21:30
$GALE Information for Galena Biopharma, Inc. From our Stock News Alerts App
Chadbourne Rolle
28 Aug 15 10:36:11
http://t.co/uIcYrAaDug Verified $59.98 profit in $GALE Bulk Import
WatchTheFunds
28 Aug 15 09:21:03
$GALE Institutional ownership up 13.89% Q/Q, with 7,747,510 net purchase http://t.co/xsraK4meAl http://t.co/CrtNcztXKX
Michael Cook
28 Aug 15 07:05:41
After 3,000% Gains In The Past Year, We Have A Major New Pick Out! Big Update: http://t.co/QTGaTmzV8y $ETEK $GALE $RSOL
Stock Rocket
28 Aug 15 06:55:33
Our Penny Stock Alerts Gained 550% In Less Than 6 Weeks! We Have A HUGE New Pick In The Works: http://t.co/wNx8NkJOZ4 $ETEK $GALE $RSOL
Stockaholics
28 Aug 15 06:33:14
Platinum Subscribers Saw Our Stock Picks Gain 4,000% In 10 Months! See Our New Pick: http://t.co/g5i9WabKUj $ETEK $GALE $RSOL
Michael James
28 Aug 15 06:30:38
Subscribers Saw A 525% Gain On $GEQU & A SECRET New Pick Is Out! See The Private Info: http://t.co/RzgF9M02nG $ETEK $GALE $RSOL
Stock Dawgzz
28 Aug 15 06:27:22
Our Platinum Members Saw Stock Picks Gin Over 550% In 5 Weeks! See Our Exclusive New Pick: http://t.co/V9CRygFGCi $ETEK $GALE $RSOL
Paul Henry
28 Aug 15 06:25:34
We Sent A SECRET New Penny Stock Pick To Our Platinum Members! Get Exclusive Special Access: http://t.co/sJCFystTVz $ETEK $GALE $RSOL
StockenheimerSchmidt
28 Aug 15 06:23:59
Our Penny Stock Picks Have Been Seeing MASSIVE gains! We Have A Big New Pick Coming: http://t.co/kfHwjHRiGg $ETEK $GALE $RSOL
Penny Stockington
28 Aug 15 06:19:22
Our Stock Alert On $GEQU Nearly QUADRUPLED In 2 Weeks! Special Update: http://t.co/EYbtsRpShV $ETEK $GALE $RSOL
Stock Market Picks
28 Aug 15 06:09:04
$FCEL $FTR $GALE $GLUU $SIRI #pennystocks, Trade Long and short or long only, up to 1900% in profits since 2011 http://t.co/yipJpHSzxe $QQQ
Consumer News
28 Aug 15 03:33:41
Weekly Investment Analysts’ Ratings Changes for Galena Biopharma $GALE http://t.co/jkYG26TIgx #acn
US Banking News
28 Aug 15 03:29:58
Weekly Investment Analysts’ Ratings Changes for Galena Biopharma $GALE http://t.co/odL8NElcdd
Ticker Report
28 Aug 15 03:28:02
Weekly Investment Analysts’ Ratings Changes for Galena Biopharma $GALE http://t.co/zMgmxfEZJl
ProTradersNews
28 Aug 15 03:20:04
$GALE: Weekly Investment Analysts’ Ratings Changes for Galena …: http://t.co/Jpr9SRyx46
Dakota Financial
28 Aug 15 03:19:42
Weekly Investment Analysts’ Ratings Changes for Galena Biopharma $GALE http://t.co/905s7FaNGk
BreakingStocksNews
28 Aug 15 02:23:05
$TEO $GALE: Chico’s FAS Inc. (CHS) Rose Sharply After Q2 Earnings Beat …: http://t.co/P8flXMoQ9i
BreakingStocksNews
27 Aug 15 11:01:09
$GALE: Analysts Set Galena Biopharma Target Price at $5.17 (NASDAQ …: http://t.co/AxhKKu5ysG
Stock Market Picks
27 Aug 15 06:29:43
$FCEL $FTR $GALE $GLUU $SIRI #pennystocks, Trade Long and short or long only, up to 1900% in profits since 2011 http://t.co/yipJpHSzxe $QQQ
Greg David
27 Aug 15 06:06:00
http://t.co/APzP66vnr4 IN PLAY: $GALE $CPE $MEMP $OXIS $PDLI $MUX $BVN $AMDA $HLX $LLBO $CABN $SGYP $HERO $ERF http://t.co/zcoOylfgJ2
brian sweetheart
27 Aug 15 06:01:34
Voted top trading group. http://t.co/5eVXN8RJLp Related: $MHR $VICL $MCP $GALE $XCO $GSAT
Penny Stocks Buzz
27 Aug 15 01:52:13
Current Trade News Analysis on: Galena Biopharma Inc $GALE Canadian
Stockaholics
26 Aug 15 22:25:58
Platinum Subscribers Saw Our Stock Picks Gain 4,000% In 10 Months! See Our New Pick: http://t.co/g5i9WatmiT $ETEK $GALE $RSOL
Stock Rocket
26 Aug 15 22:23:54
Our Penny Stock Alerts Gained 550% In Less Than 6 Weeks! We Have A HUGE New Pick In The Works: http://t.co/wNx8NkJOZ4 $ETEK $GALE $RSOL
StockenheimerSchmidt
26 Aug 15 22:21:40
Our Penny Stock Picks Have Been Seeing MASSIVE gains! We Have A Big New Pick Coming: http://t.co/kfHwjHzHOI $ETEK $GALE $RSOL
Stock Dawgzz
26 Aug 15 22:21:03
Our Platinum Members Saw Stock Picks Gin Over 550% In 5 Weeks! See Our Exclusive New Pick: http://t.co/V9CRygFGCi $ETEK $GALE $RSOL
Penny Stockington
26 Aug 15 22:17:44
Our Stock Alert On $GEQU Nearly QUADRUPLED In 2 Weeks! Special Update: http://t.co/EYbtsRpShV $ETEK $GALE $RSOL
Stock Market Picks
26 Aug 15 18:25:25
$FCEL $FTR $GALE $GLUU $SIRI #pennystocks, Trade Long and short or long only, up to 1900% in profits since 2011 http://t.co/yipJpHSzxe $QQQ
WhiteCoatMafia
26 Aug 15 17:34:09
$GALE still on for either a reload in the 1.30's, or just build into September when I'll sell other half. $GERN loading zone - don't miss it
WatchTheFunds
26 Aug 15 17:27:03
$GALE Institutional ownership up 13.89% Q/Q, with 7,747,510 net purchase http://t.co/xsraK4meAl http://t.co/q7geBHYRA9
Paul Henry
26 Aug 15 16:30:51
We Sent A SECRET New Penny Stock Pick To Our Platinum Members! Get Exclusive Special Access: http://t.co/sJCFysLuN7 $ETEK $GALE $RSOL
Michael James
26 Aug 15 16:28:27
Subscribers Saw A 525% Gain On $GEQU & A SECRET New Pick Is Out! See The Private Info: http://t.co/RzgF9MhDfe $ETEK $GALE $RSOL
Michael Cook
26 Aug 15 16:28:08
After 3,000% Gains In The Past Year, We Have A Major New Pick Out! Big Update: http://t.co/QTGaTmijJY $ETEK $GALE $RSOL
dailystockplays.com
26 Aug 15 15:18:55
Bearish Engulfing http://t.co/mv8axvHLVr $CYOU $SGU $LPI $VUZI $GALE $RADA $NWAV
Bryon Franzen
26 Aug 15 14:46:01
@megtirrell that would be a dream team $gale
Stocks News&Markets
26 Aug 15 13:30:51
Nate made $932 on $GALE -Check it out! http://t.co/VL1BcnUBKK Learn #howtotrade http://t.co/axK8SMSgo9 $ABGB $FORD $IPDN $LRE $PSUN
StockNewsWires
26 Aug 15 10:33:03
$GALE: Galena Biopharma, Inc. (NASDAQ:GALE) Brokerage Rating Update: http://t.co/2FFW17MB0J
12Stocks.com
26 Aug 15 08:53:29
SmallCap #Stocks Trend $CVGW $NMBL $BEAT $UBNT $LXRX $GALE $JOE $ABCD $CYBX $ARAY $LMAT $TRAK $RTK more@ http://t.co/Giravo3fg9
Alexander Morris
26 Aug 15 07:50:04
$GALE: Waterfall-:1 [-7%,.3%offLo], 0NearLo, PrvCHi, AtPivS1, tf:0110000; TLM:1.1, 1WkHi-, DyVol:938T:0.4x:0.4x, DyRng:8.6%:0.9x:0.9x,
Penny Stocks Blog
26 Aug 15 07:22:02
RT @stock_forums: XLP Consumer Staples Select Sector SPDR Investor Opinions http://t.co/8dlOzh9up5 $XLP $FRC.TO $GALE $TQQQ #XLP #pennysto…
Dave
26 Aug 15 07:13:18
http://t.co/L46QQZciCc IN PLAY: $GALE $CPE $MEMP $OXIS $PDLI $MUX $BVN $AMDA $HLX $LLBO $CABN $SGYP $HERO $ERF http://t.co/6G08WP6Kbp
Alpha Maven Alerts
26 Aug 15 07:03:53
$GALE active, relative volume: 8.78, 1H, 10:00 AM, #nasdaq
Emylers
26 Aug 15 06:50:43
XLV Health Care Select Sector SPDR Prev Close http://t.co/6VunkHBH2s $XLV $GALE $MMM $SKX #XLV #finance #share
danrocks
26 Aug 15 06:50:39
XLK Technology Select Sector SPDR Change http://t.co/8RLGO9McVl $XLK $HGU.TO $GALE $BABA #XLK #stocks #share
danrocks
26 Aug 15 06:50:39
WFC Wells Fargo & Co. Stock Message Board http://t.co/5wCktAdSWZ $WFC $GALE $SBUX $EEM #WFC #share #pennystocks
Stock Forums
26 Aug 15 06:50:34
XLP Consumer Staples Select Sector SPDR Investor Opinions http://t.co/8dlOzh9up5 $XLP $FRC.TO $GALE $TQQQ #XLP #pennystocks #stocks
				
				
By  +Follow February 14, 2014 5:26AM
Share:

Comments

 

blog comments powered by Disqus

 Today's Must Reads

Welcome to Equities.com's Small-Cap Throwdown


These Analysts Called Apple's (AAPL) Collapse, Here's What They're Saying Now

7 Dow Stocks Worth Owning and a Lot that Aren't

Sprint Turnaround Has Begun


Saving the

Small-Cap Market

 

Small-cap stocks offer investors many benefits, ranging from higher growth potential to overlooked value opportuni... in Equities.com's Hangs on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN